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ETATE-OF-THE-ART PAPER841Thoracic Aortic Aneurysmohn A. Elefteriades, Emily A. Farkas
lefteriades and Farkas review several controversial questions regarding the diagnosis and
anagement of thoracic aortic disease. The first section discusses the utility of various
maging modalities and problems that can arise from comparing different techniques;
mphasis is placed on the fact that these are generally slow growing (1 mm/year), and a
udden change in measured size may not reflect a true change. The evidence, both
pidemiologic and from a mechanical perspective, for recommending surgical repair when the
orta reaches 5.5 cm is reviewed. The potential for diagnosis with the use of both serum and
enetic markers is reviewed with comments on how these markers may be biologically active.
inally, the authors review recently announced long-term studies that question the utility of
ndovascular stenting for aortic aneurysms.CLINICAL RESEARCH LINICAL TRIALS858No Long-Term Benefit to Early Invasive Strategy in ICTUS TrialHR 1.29 (95% CI: 1.00−1.66) p=0.0530
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Early invasiveeter Damman, Alexander Hirsch, Fons Windhausen, Jan G. P. Tijssen, Robbert J. de Winter,
or the ICTUS Investigators
hether an early invasive or a selective invasive strategy is preferable for patients presenting
ith non–ST-segment elevation acute coronary syndromes is still debated. Damman and
olleagues report the 5-year outcomes from the ICTUS (Invasive versus Conservative
reatment in Unstable coronary Syndromes) trial, which randomized 1,200 patients to an
arly invasive or selective invasive strategy with a main end point of a composite of death or
yocardial infarction (MI). At 5-year follow-up, revascularization rates were 81% in the early
nvasive group and 60% in the selective invasive group. Cumulative death or MI rates were
2% and 18%, respectively (hazard ratio: 1.3), favoring a selective invasive strategy but of
orderline statistical significance. The results were similar when subjects were stratified by
heir presenting FRISC (Fast Revascularization in InStability in Coronary artery disease)
core. These 5-year results suggest equivalence for early invasive or selective invasive strategies,
ut the trends favor a more conservative approach.
ditorial Comment: John A. Bittl, David J. Maron, p. 865(continued on page A-22)
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867ncreased Risk of Stent Thrombosis and TLR With
the Use of Distal Protection Device in STEMI Patientsnne Kaltoft, Henning Kelbæk, Lene Kløvgaard, Christian Juhl Terkelsen, Peter Clemmensen,
teffen Helqvist, Jens Flensted Lassen, Leif Thuesen
se of distal filter protection during primary percutaneous coronary intervention (PCI) is
hought to reduce distal embolization but may increase procedure complexity and influence
esion treatment and stent implantation. Kaltoft and colleagues report the cumulative
5-month outcomes from over 600 patients undergoing primary PCI who were randomized
o distal protection (DP) or conventional treatment (CT). The rate of definite stent
hrombosis was significantly increased in the DP group as compared with the CT group,
ith 9 cases versus 1 case (p  0.01). Clinically-driven target lesion revascularization and
arget vessel revascularization were both significantly increased in the DP group. The authors
ostulate that the DP is either causing trauma to the arterial wall or is interfering with the
orrect positioning or sizing of the stent.EART FAILURE
872he ESCAPE Risk Model Quantifies 6-Month Risk
of Death or Readmission for HF Patientshristopher M. O’Connor, Vic Hasselblad, Rajendra H. Mehta, Gudaye Tasissa, Robert M. Califf,
ona Fiuzat, Joseph G. Rogers, Carl V. Leier, Lynne W. Stevenson
’Connor and colleagues created a predictive model using variables obtained from the
SCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery
atheterization Effectiveness) trial of patients with systolic dysfunction who were hospitalized
ith heart failure (HF). The risk model consists of only 8 variables, with higher risk for age
70 years, blood urea nitrogen (BUN) 40 mg/dl, 6-min walk 300 feet, sodium 130
Eq/l, cardiopulmonary resuscitation/mechanical ventilation during hospitalization, diuretic
ose 240 mg equivalents of furosemide at discharge, no beta-blocker at discharge, and
ischarge B-type natriuretic peptide (BNP) 500 pg/mmol. An extra point is assigned for
UN 90 mg/dl, and 3 points for discharge BNP 1,300 pg/mmol. This simplified
ischarge score discriminated mortality risk from 5% (score  0) to 94% (score  8). The
SCAPE discharge risk model, which is completed after in-hospital therapy for
ecompensated systolic HF, may allow clinicians to focus surveillance and triage on the
ighest-risk patients.(continued on page A-24)
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FRISC score (5-7)
HR 1.15 (95% CI: 0.66-2.03, p=0.62)
FRISC score (3-4)
HR 1.06 (95% CI: 0.74-1.52, p=0.74)
FRISC score (1-2)
HR 1.13 (95% CI: 0.57-2.24, p=0.72). Jan Willem Borleffs, Johannes B. van Rees, Guido H. van Welsenes, Enno T. van der Velde,
ieselot van Erven, Jeroen J. Bax, Martin J. Schalij
orleffs and colleagues determined the prevalence of different types of atrial fibrillation (AF)
nd their prognostic importance in implantable cardioverter-defibrillator (ICD) patients. Data
n nearly 1,000 consecutive patients receiving an ICD were prospectively collected, including
he existence and type of AF (paroxysmal, persistent, or permanent). During a median 2.5
ears of follow-up, 13% of patients died, 25% experienced appropriate device discharge, and
5% received inappropriate shocks. Patients with permanent AF were twice as likely to die
nd also twice as likely to have both appropriate and inappropriate device therapy. Patients
ith paroxysmal or persistent AF were not at increased risk for death or appropriate device
herapy, but were almost three times more likely to receive inappropriate device therapy. The
resence of AF has important prognostic implications for mortality, as well as appropriate and
nappropriate device discharge.EART RHYTHM DISORDERS886Infected Intracardiac Leads Can Be Safely Removed Percutaneouslyon A. Grammes, Christopher M. Schulze, Mohammad Al-Bataineh, George A. Yesenosky, Christine S. Saari,
ichelle J. Vrabel, Jay Horrow, Mashiul Chowdhury, John M. Fontaine, Steven P. Kutalek
rammes and colleagues describe the feasibility, safety, and clinical outcomes of percutaneous
ead extraction in 100 patients with intracardiac vegetations. The median extraction time was
min/lead. No deaths were related directly to the procedure itself. Two patients had
itnessed embolization of vegetation material, which measured 2 cm before extraction in
oth cases, and a third patient had presumptive embolization of a vegetation measuring
.2 cm. All 3 patients made a full recovery. Patients with intracardiac vegetations can safely
ndergo complete device extraction using standard percutaneous lead extraction techniques.ditorial Comment: James D. Maloney, James D. Maloney III, p. 895ASCULAR DISEASE898Higher Risk Seen in PAD Patients With Proximal Lesionsictor Aboyans, Ileana Desormais, Philippe Lacroix, Johanna Salazar, Michael H. Criqui, Marc Laskar
eripheral arterial disease (PAD) is associated with increased risk of cardiovascular (CV)
vents, but it is unknown whether the risks vary according to the location of the disease. This
tudy by Aboyans and colleagues reviewed lower limb digital subtraction angiography studies
rom 400 patients who were then followed for cardiovascular events and death. Aorto-iliac
isease (proximal PAD) and infra-iliac disease (distal PAD) were noted in 53% and 63%,
espectively. Male sex and smoking were more prevalent in proximal PAD while older age,
iabetes, hypertension, and renal failure were more prevalent in distal PAD. After adjustment
or clinical variables, the risk of both a CV event and death were 3 times higher in those with
roximal PAD compared with distal PAD. This is the first study to report worse prognosis
f patients with proximal PAD compared with those with more distal PAD, independent of
isk factors and comorbidities.(continued on page A-30)
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rRE-CLINICAL RESEARCH904siRNA Can Be Targeted to the Arterial Wall Using Microbubbles and Ultrasoundun-ichi Suzuki, Masahito Ogawa, Kiyoshi Takayama, Yoshiaki Taniyama, Ryuichi Morishita,
asunobu Hirata, Ryozo Nagai, Mitsuaki Isobe
uzuki and colleagues investigated the feasibility of delivering small interfering ribonucleic
cid (siRNA) to the arterial wall. siRNA can be easily synthesized and effectively suppresses
rotein translation; however, it has proven difficult to design an effective in vivo delivery
ystem. A murine model was constructed where the femoral artery was temporally ligated,
nd microbubbles containing the siRNA of interest were infused. Ultrasound was then used
o locally destroy the microbubbles; flow in the artery was then restored. This method
uccessfully inhibited the expression of green fluorescent protein in the local arterial wall in
ice bred to systemically express this protein. The method was then used to transfect an
iRNA to inhibit expression of intercellular adhesion molecule-1; this transfection suppressed
he development of neointimal formation after arterial injury. This method of transfecting
iRNA into the arterial wall may prove effective for a variety of disorders.ditorial Comment: Christian Kupatt, p. 914NEWS FROM THE NHLBI EWS FROM THE NHLBI917Obesity Research and Programs at the NHLBIIncreases knowledge about
biological and behavioral
associations and mechanisms
Basic Research 
and Epidemiology
Efficacy Clinical
Trials
Determines efficacy of 
interventions under tightly 
controlled circumstances
Intervention Studies In 
Community Settings
Determines effectiveness
of interventions in 
“real world” settings
Translation &
Dissemination Activities
Translates & disseminates
intervention approaches to 
clinical & community settings
Bi
-directionalhis paper from the National Heart, Lung, and Blood Institute (NHLBI) describes the
ctivities of the Institute to address the growing public health problem of obesity. Major
besity-related activities where the NHLBI was the lead institute over the past several
ecades are divided into 4 categories: 1) epidemiologic and basic research; 2) efficacy clinical
rials; 3) effectiveness studies; and 4) obesity-related translation and dissemination activities.
hese activities inform each other bidirectionally and will hopefully lead to interventions to
educe the cardiovascular burden associated with growing rates of obesity.
